Pfizer acquiring Park City pharmaceutical company for $6.7 billion
Pfizer announced Monday its plans to acquire Utah drugmaker that develops immunotherapies to treat inflammatory diseases. |!| Park City
Pfizer announced Monday its plans to acquire Utah drugmaker that develops immunotherapies to treat inflammatory diseases. |!| Park City